13 Mar 2008 11:05
FORM 8.3 DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE (Rule 8.3 of the Takeover Code)
1. KEY INFORMATION
Name of person dealing (Note 1) Church House Investments Limited Company dealt in Tissue Science Laboratories PLC Class of relevant security to Ordinary 10p
which the dealings being disclosed relate (Note 2) Date of dealing 12th March 2008
2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE
(a) Interests and short positions (following dealing) in the class of relevantsecurity dealt in (Note 3) Long Short Number (%) Number (%) (1) Relevant securities 0 0% (2) Derivatives (other than options) (3) Options and agreements to purchase/sell Total
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Long Short Number (%) Number (%) (1) Relevant securities (2) Derivatives (other than options)
(3) Options and agreements to purchase/sell Total
(c) Rights to subscribe (Note 3)
Class of relevant security: Details 3. DEALINGS (Note 4)(a) Purchases and salesPurchase/sale Number of securities Price per unit (Note 5) Sale 794,500 1.0150
(b) Derivatives transactions (other than options)
Product name, Long/short (Note Number of securities Price per unit (Note e.g. CFD 6)
(Note 7) 5)
(c) Options transactions in respect of existing securities
(i) Writing, selling, purchasing or varying
Product name, Writing, Number of Exercise Type, e.g. Expiry Option e.g. call selling, securities to price American, date money option purchasing, which the European paid/ varying option etc. received etc. relates (Note per unit 7) (Note 5) (ii) ExercisingProduct name, e.g. call Number of securities Exercise price per unit option (Note 5)
(d) Other dealings (including new securities) (Note 4)
Nature of transaction Details Price per unit (if (Note 8) applicable) (Note 5) 4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
Is a Supplemental Form 8 attached? (Note 9) [YES/NO] -
Date of disclosure 13th March 2008 Contact name Roger Davis Telephone number 01935 382657
If a connected EFM, name of offeree/offeror with which connected If a connected EFM, state nature of connection (Note 10)
Notes
The Notes on Form 8.3 can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk
TISSUE SCIENCE LABORATORIES PLC